The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Next Generation Sequencers Market Research Report 2025
Synopsis
Next generatio sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.
Knowledge of DNA sequences has become indispensable for basic biological research, and in numerous applied fields such as medical diagnosis, biotechnology, forensic biology, virology and biological systematics. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of complete DNA sequences, or genomes of numerous types and species of life, including the human genome and other complete DNA sequences of many animal, plant, and microbial species.
The global Next Generation Sequencers market was valued at US$ 3690.2 million in 2023 and is anticipated to reach US$ 4346.4 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Next Generation Sequencers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation Sequencers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next Generation Sequencers in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next Generation Sequencers include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg) and Oxford Nanopore Technologies, Ltd. (UK), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencers.
Report Scope
The Next Generation Sequencers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Sequencers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
Segment by Type
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Segment by Application
Diagnostics
Drug Discovery
Biomarker Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Sequencers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Next generatio sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases—adenine, guanine, cytosine, and thymine—in a strand of DNA. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.
Knowledge of DNA sequences has become indispensable for basic biological research, and in numerous applied fields such as medical diagnosis, biotechnology, forensic biology, virology and biological systematics. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of complete DNA sequences, or genomes of numerous types and species of life, including the human genome and other complete DNA sequences of many animal, plant, and microbial species.
The global Next Generation Sequencers market was valued at US$ 3690.2 million in 2023 and is anticipated to reach US$ 4346.4 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Next Generation Sequencers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation Sequencers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next Generation Sequencers in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next Generation Sequencers include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), Roche Holding AG (Switzerland), QIAGEN N. V. (Germany), BGI (China), Macrogen Inc. (South Korea), Eurofins Scientific (Luxembourg) and Oxford Nanopore Technologies, Ltd. (UK), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencers.
Report Scope
The Next Generation Sequencers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Sequencers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pacific Biosciences of California, Inc. (US)
Roche Holding AG (Switzerland)
QIAGEN N. V. (Germany)
BGI (China)
Macrogen Inc. (South Korea)
Eurofins Scientific (Luxembourg)
Oxford Nanopore Technologies, Ltd. (UK)
Otogenetics Corporation (US)
Segment by Type
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-Molecule Real-time (SMRT) Sequencing
Other
Segment by Application
Diagnostics
Drug Discovery
Biomarker Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Sequencers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sequencing by Synthesis (SBS)
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-Molecule Real-time (SMRT) Sequencing
1.2.5 Other
1.3 Market by Application
1.3.1 Global Next Generation Sequencers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Biomarker Discovery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencers Market Perspective (2019-2030)
2.2 Next Generation Sequencers Growth Trends by Region
2.2.1 Global Next Generation Sequencers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation Sequencers Historic Market Size by Region (2019-2024)
2.2.3 Next Generation Sequencers Forecasted Market Size by Region (2025-2030)
2.3 Next Generation Sequencers Market Dynamics
2.3.1 Next Generation Sequencers Industry Trends
2.3.2 Next Generation Sequencers Market Drivers
2.3.3 Next Generation Sequencers Market Challenges
2.3.4 Next Generation Sequencers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencers Players by Revenue
3.1.1 Global Top Next Generation Sequencers Players by Revenue (2019-2024)
3.1.2 Global Next Generation Sequencers Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation Sequencers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencers Revenue
3.4 Global Next Generation Sequencers Market Concentration Ratio
3.4.1 Global Next Generation Sequencers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencers Revenue in 2023
3.5 Next Generation Sequencers Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencers Product Solution and Service
3.7 Date of Enter into Next Generation Sequencers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencers Breakdown Data by Type
4.1 Global Next Generation Sequencers Historic Market Size by Type (2019-2024)
4.2 Global Next Generation Sequencers Forecasted Market Size by Type (2025-2030)
5 Next Generation Sequencers Breakdown Data by Application
5.1 Global Next Generation Sequencers Historic Market Size by Application (2019-2024)
5.2 Global Next Generation Sequencers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation Sequencers Market Size (2019-2030)
6.2 North America Next Generation Sequencers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation Sequencers Market Size by Country (2019-2024)
6.4 North America Next Generation Sequencers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencers Market Size (2019-2030)
7.2 Europe Next Generation Sequencers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation Sequencers Market Size by Country (2019-2024)
7.4 Europe Next Generation Sequencers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencers Market Size (2019-2030)
8.2 Asia-Pacific Next Generation Sequencers Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation Sequencers Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation Sequencers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencers Market Size (2019-2030)
9.2 Latin America Next Generation Sequencers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation Sequencers Market Size by Country (2019-2024)
9.4 Latin America Next Generation Sequencers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencers Market Size (2019-2030)
10.2 Middle East & Africa Next Generation Sequencers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation Sequencers Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation Sequencers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina, Inc. (US)
11.1.1 Illumina, Inc. (US) Company Detail
11.1.2 Illumina, Inc. (US) Business Overview
11.1.3 Illumina, Inc. (US) Next Generation Sequencers Introduction
11.1.4 Illumina, Inc. (US) Revenue in Next Generation Sequencers Business (2019-2024)
11.1.5 Illumina, Inc. (US) Recent Development
11.2 Thermo Fisher Scientific, Inc. (US)
11.2.1 Thermo Fisher Scientific, Inc. (US) Company Detail
11.2.2 Thermo Fisher Scientific, Inc. (US) Business Overview
11.2.3 Thermo Fisher Scientific, Inc. (US) Next Generation Sequencers Introduction
11.2.4 Thermo Fisher Scientific, Inc. (US) Revenue in Next Generation Sequencers Business (2019-2024)
11.2.5 Thermo Fisher Scientific, Inc. (US) Recent Development
11.3 Pacific Biosciences of California, Inc. (US)
11.3.1 Pacific Biosciences of California, Inc. (US) Company Detail
11.3.2 Pacific Biosciences of California, Inc. (US) Business Overview
11.3.3 Pacific Biosciences of California, Inc. (US) Next Generation Sequencers Introduction
11.3.4 Pacific Biosciences of California, Inc. (US) Revenue in Next Generation Sequencers Business (2019-2024)
11.3.5 Pacific Biosciences of California, Inc. (US) Recent Development
11.4 Roche Holding AG (Switzerland)
11.4.1 Roche Holding AG (Switzerland) Company Detail
11.4.2 Roche Holding AG (Switzerland) Business Overview
11.4.3 Roche Holding AG (Switzerland) Next Generation Sequencers Introduction
11.4.4 Roche Holding AG (Switzerland) Revenue in Next Generation Sequencers Business (2019-2024)
11.4.5 Roche Holding AG (Switzerland) Recent Development
11.5 QIAGEN N. V. (Germany)
11.5.1 QIAGEN N. V. (Germany) Company Detail
11.5.2 QIAGEN N. V. (Germany) Business Overview
11.5.3 QIAGEN N. V. (Germany) Next Generation Sequencers Introduction
11.5.4 QIAGEN N. V. (Germany) Revenue in Next Generation Sequencers Business (2019-2024)
11.5.5 QIAGEN N. V. (Germany) Recent Development
11.6 BGI (China)
11.6.1 BGI (China) Company Detail
11.6.2 BGI (China) Business Overview
11.6.3 BGI (China) Next Generation Sequencers Introduction
11.6.4 BGI (China) Revenue in Next Generation Sequencers Business (2019-2024)
11.6.5 BGI (China) Recent Development
11.7 Macrogen Inc. (South Korea)
11.7.1 Macrogen Inc. (South Korea) Company Detail
11.7.2 Macrogen Inc. (South Korea) Business Overview
11.7.3 Macrogen Inc. (South Korea) Next Generation Sequencers Introduction
11.7.4 Macrogen Inc. (South Korea) Revenue in Next Generation Sequencers Business (2019-2024)
11.7.5 Macrogen Inc. (South Korea) Recent Development
11.8 Eurofins Scientific (Luxembourg)
11.8.1 Eurofins Scientific (Luxembourg) Company Detail
11.8.2 Eurofins Scientific (Luxembourg) Business Overview
11.8.3 Eurofins Scientific (Luxembourg) Next Generation Sequencers Introduction
11.8.4 Eurofins Scientific (Luxembourg) Revenue in Next Generation Sequencers Business (2019-2024)
11.8.5 Eurofins Scientific (Luxembourg) Recent Development
11.9 Oxford Nanopore Technologies, Ltd. (UK)
11.9.1 Oxford Nanopore Technologies, Ltd. (UK) Company Detail
11.9.2 Oxford Nanopore Technologies, Ltd. (UK) Business Overview
11.9.3 Oxford Nanopore Technologies, Ltd. (UK) Next Generation Sequencers Introduction
11.9.4 Oxford Nanopore Technologies, Ltd. (UK) Revenue in Next Generation Sequencers Business (2019-2024)
11.9.5 Oxford Nanopore Technologies, Ltd. (UK) Recent Development
11.10 Otogenetics Corporation (US)
11.10.1 Otogenetics Corporation (US) Company Detail
11.10.2 Otogenetics Corporation (US) Business Overview
11.10.3 Otogenetics Corporation (US) Next Generation Sequencers Introduction
11.10.4 Otogenetics Corporation (US) Revenue in Next Generation Sequencers Business (2019-2024)
11.10.5 Otogenetics Corporation (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
